Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
619
Frequently Asked Questions
What is Market Cap of Adaptive Biotechnologies Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adaptive Biotechnologies Corp market cap is $2.57B.
What is the 52-week high for Adaptive Biotechnologies Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adaptive Biotechnologies Corp 52 week high is $17.89 as of October 29, 2025.
What is the 52-week low for Adaptive Biotechnologies Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adaptive Biotechnologies Corp 52 week low is $4.27 as of October 29, 2025.
What is Adaptive Biotechnologies Corp stock price today?
Adaptive Biotechnologies Corp stock price today is $16.90.
What was Adaptive Biotechnologies Corp stock price yesterday?
Adaptive Biotechnologies Corp stock price yesterday was $17.12.
What is the PE ratio of Adaptive Biotechnologies Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Adaptive Biotechnologies Corp’s P/E ratio is -20.76.
What is the Price-to-Book ratio of Adaptive Biotechnologies Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Adaptive Biotechnologies Corp P/B ratio is 14.3156.
What is the 50-day moving average of Adaptive Biotechnologies Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adaptive Biotechnologies Corp 50-day moving average is $14.24.
How many employess does Adaptive Biotechnologies Corp has?